Literature DB >> 16326799

Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.

R Arkader1, E J Troster, M R Lopes, R R Júnior, J A Carcillo, C Leone, T S Okay.   

Abstract

AIMS: To evaluate whether procalcitonin (PCT) and C reactive protein (CRP) are able to discriminate between sepsis and systemic inflammatory response syndrome (SIRS) in critically ill children.
METHODS: Prospective, observational study in a paediatric intensive care unit. Kinetics of PCT and CRP were studied in patients undergoing open heart surgery with cardiopulmonary bypass (CPB) (SIRS model; group I1) and patients with confirmed bacterial sepsis (group II).
RESULTS: In group I, PCT median concentration was 0.24 ng/ml (reference value <2.0 ng/ml). There was an increment of PCT concentrations which peaked immediately after CPB (median 0.58 ng/ml), then decreased to 0.47 ng/ml at 24 h; 0.33 ng/ml at 48 h, and 0.22 ng/ml at 72 h. CRP median concentrations remained high on POD1 (36.6 mg/l) and POD2 (13.0 mg/l). In group II, PCT concentrations were high at admission (median 9.15 ng/ml) and subsequently decreased in 11/14 patients who progressed favourably (median 0.31 ng/ml). CRP levels were high in only 11/14 patients at admission. CRP remained high in 13/14 patients at 24 h; in 12/14 at 48 h; and in 10/14 patients at 72 h. Median values were 95.0, 50.9, 86.0, and 20.3 mg/l, respectively. The area under the ROC curve was 0.99 for PCT and 0.54 for CRP. Cut off concentrations to differentiate SIRS from sepsis were >2 ng/ml for PCT and >79 mg/l for CRP.
CONCLUSION: PCT is able to differentiate between SIRS and sepsis while CRP is not. Moreover, unlike CRP, PCT concentrations varied with the evolution of sepsis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326799      PMCID: PMC2082702          DOI: 10.1136/adc.2005.077446

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  27 in total

1.  C-reactive protein in patients undergoing cardiac surgery.

Authors:  H Boralessa; F C de Beer; A Manchie; J G Whitwam; M B Pepys
Journal:  Anaesthesia       Date:  1986-01       Impact factor: 6.955

Review 2.  Septic shock.

Authors:  J A Carcillo; R E Cunnion
Journal:  Crit Care Clin       Date:  1997-07       Impact factor: 3.598

Review 3.  Pediatric septic shock and multiple organ failure.

Authors:  Joseph A Carcillo
Journal:  Crit Care Clin       Date:  2003-07       Impact factor: 3.598

4.  Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.

Authors:  Anna Fernández Lopez; C Luaces Cubells; J J García García; J Fernández Pou
Journal:  Pediatr Infect Dis J       Date:  2003-10       Impact factor: 2.129

5.  Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients.

Authors:  Ronaldo Arkader; Eduardo Juan Troster; Deipara Monteiro Abellan; Marcel Rezende Lopes; Roberto Raiz Júnior; Joseph A Carcillo; Thelma Suely Okay
Journal:  J Cardiothorac Vasc Anesth       Date:  2004-04       Impact factor: 2.628

Review 6.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

Authors:  Liliana Simon; France Gauvin; Devendra K Amre; Patrick Saint-Louis; Jacques Lacroix
Journal:  Clin Infect Dis       Date:  2004-07-02       Impact factor: 9.079

7.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.

Authors:  M S Rangel-Frausto; D Pittet; M Costigan; T Hwang; C S Davis; R P Wenzel
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

8.  Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis.

Authors:  M Sauer; K Tiede; D Fuchs; B Gruhn; D Berger; F Zintl
Journal:  Bone Marrow Transplant       Date:  2003-06       Impact factor: 5.483

9.  Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis.

Authors:  Yong Y Han; Lesley A Doughty; Danny Kofos; Howell Sasser; Joseph A Carcillo
Journal:  Pediatr Crit Care Med       Date:  2003-01       Impact factor: 3.624

10.  Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response.

Authors:  S Tugrul; F Esen; S Celebi; P E Ozcan; O Akinci; N Cakar; L Telci
Journal:  Anaesth Intensive Care       Date:  2002-12       Impact factor: 1.669

View more
  30 in total

Review 1.  Year in Review in Intensive Care Medicine, 2006. III. Circulation, ethics, cancer, outcome, education, nutrition, and pediatric and neonatal critical care.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard
Journal:  Intensive Care Med       Date:  2007-02-14       Impact factor: 17.440

Review 2.  Emerging infection and sepsis biomarkers: will they change current therapies?

Authors:  Lauren Jacobs; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-17       Impact factor: 5.091

Review 3.  Biomarkers for pediatric sepsis and septic shock.

Authors:  Stephen W Standage; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

4.  Association of Procalcitonin Value and Bacterial Coinfections in Pediatric Patients With Viral Lower Respiratory Tract Infections Admitted to the Pediatric Intensive Care Unit.

Authors:  John J Kotula; Wayne S Moore; Arun Chopra; Jeffrey J Cies
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Nov-Dec

5.  Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.

Authors:  Corsino Rey; Marta Los Arcos; Andrés Concha; Alberto Medina; Soledad Prieto; Pablo Martinez; Belen Prieto
Journal:  Intensive Care Med       Date:  2007-01-27       Impact factor: 17.440

6.  Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children.

Authors:  Mojca Groselj-Grenc; Alojz Ihan; Maja Pavcnik-Arnol; Andreja Natasa Kopitar; Tanja Gmeiner-Stopar; Metka Derganc
Journal:  Intensive Care Med       Date:  2009-11       Impact factor: 17.440

7.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

8.  Current concepts in the diagnosis and management of cytokine release syndrome.

Authors:  Daniel W Lee; Rebecca Gardner; David L Porter; Chrystal U Louis; Nabil Ahmed; Michael Jensen; Stephan A Grupp; Crystal L Mackall
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

9.  Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children.

Authors:  Maja Pavcnik-Arnol; Sergej Hojker; Metka Derganc
Journal:  Intensive Care Med       Date:  2007-04-05       Impact factor: 17.440

10.  Biomarkers in SIRS and sepsis: Quo vadis?

Authors:  Alexander R Novotny
Journal:  J Emerg Trauma Shock       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.